TABLE OF CONTENTS
1 INTRODUCTION 40
1.1 OBJECTIVES OF THE STUDY 40
1.2 MARKET DEFINITION 40
1.3 OVERVIEW OF THE GLOBAL OPHTHALMOLOGY LASERS MARKET 40
1.4 CURRENCY AND PRICING 42
1.5 LIMITATIONS 42
1.6 MARKETS COVERED 42
2 GLOBAL OPHTHALMOLOGY LASERS MARKET: SEGMENTATION 45
2.1 MARKETS COVERED 45
2.2 GEOGRAPHICAL SCOPE 46
2.3 YEARS CONSIDERED FOR THE STUDY 47
2.4 DBMR TRIPOD DATA VALIDATION MODEL 48
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 51
2.6 MULTIVARIATE MODELLING 52
2.7 PRODUCT LIFELINE CURVE 52
2.8 DBMR MARKET POSITION GRID 53
2.9 VENDOR SHARE ANALYSIS 55
2.10 MARKET END USER COVERAGE GRID 56
2.11 SECONDARY SOURCES 57
3 EXECUTIVE SUMMARY 58
4 PREMIUM INSIGHTS 61
4.1 PORTERS FIVE FORCES 63
4.2 PESTEL ANALYSIS 64
4.3 STRATEGIC INITIATIVES 65
5 GLOBAL OPHTHALMOLOGY LASERS MARKET, REGULATION 66
6 MARKET OVERVIEW 68
6.1 DRIVERS 70
6.1.1 INCREASING INCIDENCES OF CHRONIC AND COMMUNICABLE EYE DISEASES 70
6.1.2 INCREASED CONSUMER AWARENESS FOR LASER TREATMENTS 70
6.1.3 INCREASING ADOPTION OF OUTPATIENT PROCEDURES 71
6.1.4 RISING DEMAND FOR MINIMALLY INVASIVE SURGICAL PROCEDURES 72
6.2 RESTRAINTS 73
6.2.1 HIGH COST OF OPHTHALMOLOGY LASER PROCEDURES 73
6.2.2 STRINGENT REGULATORY POLICIES 73
6.3 OPPORTUNITIES 74
6.3.1 TECHNOLOGICAL ADVANCEMENTS IN OPHTHALMOLOGY 74
6.3.2 EMERGING MARKETS AND GOVERNMENT FUNDING 75
6.4 CHALLENGES 76
6.4.1 LACK OF SKILLED PROFESSIONALS 76
6.4.2 SAFETY CONCERNS 76
7 GLOBAL OPHTHALMOLOGY LASERS MARKET, BY PRODUCT 78
7.1 OVERVIEW 79
7.2 EXCIMER LASERS 82
7.2.1 ARF 83
7.2.2 KRF 83
7.2.3 XECL 83
7.2.4 XEFL 83
7.2.5 F2 83
7.2.6 XEBR 83
7.3 FEMTOSECOND LASERS 83
7.3.1 SEMICONDUCTOR LASERS 84
7.3.2 SOLID-STATE BULK LASERS 85
7.3.3 FREQUENCY-CONVERTED SOURCES 85
7.3.4 FIBER LASERS 85
7.3.5 DYE LASERS 85
7.3.6 OTHERS 85
7.4 ND:YAG LASERS 85
7.4.1 ND: YAG LASER AT 1064 NM 86
7.4.2 ND: YAG GREEN LASER AT 532 NM 86
7.5 DIODE LASERS 86
7.6 OTHERS 87
8 GLOBAL OPHTHALMOLOGY LASERS MARKET, BY TYPE 88
8.1 OVERVIEW 89
8.2 PHOTOCOAGULATION LASERS 92
8.3 SELECTIVE LASER TRABECULOPLASTY (SLT) 92
8.4 PHOTODISRUPTION LASERS 93
9 GLOBAL OPHTHALMOLOGY LASERS MARKET, BY APPLICATION 95
9.1 OVERVIEW 96
9.2 THERAPEUTICS 99
9.2.1 CATARACT REMOVAL 100
9.2.2 GLAUCOMA TREATMENT 100
9.2.3 DIABETIC RETINOPATHY TREATMENT 100
9.2.4 REFRACTIVE ERROR CORRECTION 100
9.2.5 AMD TREATMENT 100
9.2.6 OTHERS 100
9.3 DIAGNOSTICS 101
9.3.1 OPTICAL COHERENCE TOMOGRAPHY (OCT) 102
9.3.2 SCANNING LASER OPHTHALMOSCOPE (SLO) 102
10 GLOBAL OPHTHALMOLOGY LASERS MARKET, BY GASES 103
10.1 OVERVIEW 104
10.2 NOBLE GAS 107
10.2.1 ARGON 108
10.2.2 XENON 108
10.2.3 KRYPTON 108
10.3 HALOGEN GAS 108
10.3.1 CHLORINE 109
10.3.2 BROMINE 109
10.3.3 FLOURINE 109
10.4 BUFFER GAS 109
10.4.1 HELIUM 110
10.4.2 NEON 110
10.5 OTHERS 111
11 GLOBAL OPHTHALMOLOGY LASERS MARKET, BY END USER 112
11.1 OVERVIEW 113
11.2 HOSPITALS 116
11.3 CLINICS 116
11.4 OTHERS 117
12 GLOBAL OPHTHALMOLOGY LASERS MARKET, BY REGION 119
12.1 OVERVIEW 120
12.2 NORTH AMERICA 125
12.2.1 U.S. 133
12.2.2 CANADA 137
12.2.3 MEXICO 141
12.3 EUROPE 145
12.3.1 GERMANY 153
12.3.2 FRANCE 157
12.3.3 U.K. 161
12.3.4 ITALY 165
12.3.5 SPAIN 169
12.3.6 RUSSIA 173
12.3.7 TURKEY 177
12.3.8 BELGIUM 181
12.3.9 NETHERLANDS 185
12.3.10 SWITZERLAND 189
12.3.11 REST OF EUROPE 193
12.4 ASIA-PACIFIC 194
12.4.1 JAPAN 202
12.4.2 CHINA 206
12.4.3 SOUTH KOREA 210
12.4.4 INDIA 214
12.4.5 AUSTRALIA 218
12.4.6 SINGAPORE 222
12.4.7 THAILAND 226
12.4.8 MALAYSIA 230
12.4.9 INDONESIA 234
12.4.10 PHILIPPINES 238
12.4.11 VIETNAM 242
12.4.12 REST OF ASIA-PACIFIC 246
12.5 SOUTH AMERICA 247
12.5.1 BRAZIL 255
12.5.2 ARGENTINA 259
12.5.3 REST OF SOUTH AMERICA 263
12.6 MIDDLE EAST AND AFRICA 264
12.6.1 SOUTH AFRICA 273
12.6.2 SAUDI ARABIA 277
12.6.3 U.A.E. 281
12.6.4 EGYPT 285
12.6.5 ISRAEL 289
12.6.6 REST OF MIDDLE EAST AND AFRICA 293
13 GLOBAL OPHTHALMOLOGY LASERS MARKET: COMPANY LANDSCAPE 294
13.1 COMPANY SHARE ANALYSIS: GLOBAL 294
13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 295
13.3 COMPANY SHARE ANALYSIS: EUROPE 296
13.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 297
14 SWOT ANALYSIS 298
15 GLOBAL OPHTHALMOLOGY LASERS MARKET, CPS 299
15.1 BAUSCH & LOMB INCORPORATED 299
15.1.1 COMPANY SNAPSHOT 299
15.1.2 REVENUE ANALYSIS 299
15.1.3 COMPANY SHARE ANALYSIS 300
15.1.4 PRODUCT PORTFOLIO 300
15.1.5 RECENT DEVELOPMENT 300
15.2 JOHNSON & JOHNSON, INC. 301
15.2.1 COMPANY SNAPSHOT 301
15.2.2 REVENUE ANALYSIS 301
15.2.3 COMPANY SHARE ANALYSIS 302
15.2.4 PRODUCT PORTFOLIO 302
15.2.5 RECENT DEVELOPMENT 302
15.3 ZEISS 303
15.3.1 COMPANY SNAPSHOT 303
15.3.2 REVENUE ANALYSIS 303
15.3.3 COMPANY SHARE ANALYSIS 304
15.3.4 PRODUCT PORTFOLIO 304
15.3.5 RECENT DEVELOPMENT 304
15.4 ALCON 305
15.4.1 COMPANY SNAPSHOT 305
15.4.2 REVENUE ANALYSIS 305
15.4.3 COMPANY SHARE ANALYSIS 306
15.4.4 PRODUCT PORTFOLIO 306
15.4.5 RECENT DEVELOPMENT 306
15.5 NIDEK CO., LTD 307
15.5.1 COMPANY SNAPSHOT 307
15.5.2 REVENUE ANALYSIS 307
15.5.3 COMPANY SHARE ANALYSIS 308
15.5.4 PRODUCT PORTFOLIO 308
15.5.5 RECENT DEVELOPMENT 308
15.6 ARC LASER GMBH 309
15.6.1 COMPANY SNAPSHOT 309
15.6.2 PRODUCT PORTFOLIO 309
15.6.3 RECENT DEVELOPMENT 309
15.7 AUROLAB 310
15.7.1 COMPANY SNAPSHOT 310
15.7.2 PRODUCT PORTFOLIO 310
15.7.3 RECENT DEVELOPMENT 310
15.8 CALMAR LASER 311
15.8.1 COMPANY SNAPSHOT 311
15.8.2 PRODUCT PORTFOLIO 311
15.8.3 RECENT DEVELOPMENT 311
15.9 IRIDEX CORPORATION 312
15.9.1 COMPANY SNAPSHOT 312
15.9.2 REVENUE ANALYSIS 312
15.9.3 PRODUCT PORTFOLIO 313
15.9.4 RECENT DEVELOPMENT 313
15.10 IVIS TECHNOLOGIES 314
15.10.1 COMPANY SNAPSHOT 314
15.10.2 PRODUCT PORTFOLIO 314
15.10.3 RECENT DEVELOPMENT 314
15.11 LENSAR, INC. 315
15.11.1 COMPANY SNAPSHOT 315
15.11.2 REVENUE ANALYSIS 315
15.11.3 PRODUCT PORTFOLIO 316
15.11.4 RECENT DEVELOPMENT 316
15.12 LUMENIS BE LTD. 317
15.12.1 COMPANY SNAPSHOT 317
15.12.2 PRODUCT PORTFOLIO 317
15.12.3 RECENT DEVELOPMENT 317
15.13 LIGHTMED 318
15.13.1 COMPANY SNAPSHOT 318
15.13.2 PRODUCT PORTFOLIO 318
15.13.3 RECENT DEVELOPMENT 318
15.14 MEDA CO., LTD. 319
15.14.1 COMPANY SNAPSHOT 319
15.14.2 PRODUCT PORTFOLIO 319
15.14.3 RECENT DEVELOPMENT 319
15.15 OD-OS 320
15.15.1 COMPANY SNAPSHOT 320
15.15.2 PRODUCT PORTFOLIO 320
15.15.3 RECENT DEVELOPMENT 320
15.16 QUANTEL MEDICAL (A SUBSIDIARY OF LUMIBIRD MEDICAL) 321
15.16.1 COMPANY SNAPSHOT 321
15.16.2 REVENUE ANALYSIS 321
15.16.3 PRODUCT PORTFOLIO 322
15.16.4 RECENT DEVELOPMENT 322
15.17 SCHWIND EYE-TECH-SOLUTIONS 323
15.17.1 COMPANY SNAPSHOT 323
15.17.2 PRODUCT PORTFOLIO 323
15.17.3 RECENT DEVELOPMENT 323
15.18 TOPCON 324
15.18.1 COMPANY SNAPSHOT 324
15.18.2 REVENUE ANALYSIS 324
15.18.3 PRODUCT PORTFOLIO 325
15.18.4 RECENT DEVELOPMENT 325
15.19 ZIEMER OPHTHALMIC SYSTEMS AG 326
15.19.1 COMPANY SNAPSHOT 326
15.19.2 PRODUCT PORTFOLIO 326
15.19.3 RECENT DEVELOPMENT 326
16 QUESTIONNAIRE 327
17 RELATED REPORTS 330

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.